ARCHIVES

Changes In Labels Of Anticancer Drugs Suggested; Response Is Slow

This article is from The Cancer Letter archive.

Vol. 02 No. 41 | October 8, 1976

Download PDF Visit The Full Archive

Related Articles

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

Four CIDAC Contracts Will Go To Cancer Research Centers; RFPs To Be Released January or February

December 20, 1974

Laertrile Clinical Study Provides Solid Evidence: It Is Useless

May 8, 1981

AACI Committee Makes Case For Clinical Research In Centers; Cancer Control, Group Funds Eyed

December 8, 1978

In the States: Michigan to Allocate $50 Million Annually To Life Sciences

July 23, 1999

Sarcoma Survivors At Risk Of Blood Clots, Study Finds

May 25, 2007